Feed aggregator
French National Center for Scientific Research faulted over chemistry lab misconduct probe
Institution needs to take firmer action in case, letter writers say
Volastra licenses Amgen molecule for chromosomally unstable cancers
Start-up also brings in $60 million series A
5 lessons from a year of implementing the ACS Inclusivity Style Guide
Inclusive language and images make C&EN more accurate and respectful
Flagship unveils latest brainchild: Ampersand Biomedicines
The venture capital company commits $50 million to the start-up launch